Quantitative Analysis of Norfloxacin in β-Cyclodextrin Inclusion Complexes—Development and Validation of a Stability-indicating HPLC Method

被引:0
作者
Cassiana Mendes
Aline Buttchevitz
Jéssica Henriques Kruger
Larissa Sakis Bernardi
Paulo Renato Oliveira
Marcos Antônio Segatto Silva
机构
[1] Federal University of Santa Catarina (UFSC),Post Graduation Program in Pharmaceutical Sciences, Quality Control Laboratory
[2] Universidade Estadual do Centro Oeste/UNICENTRO,Post Graduation Program in Pharmaceutical Sciences
来源
Analytical Sciences | 2015年 / 31卷
关键词
-Cyclodextrin; fluorescence detection; high performance liquid chromatography; inclusion complex; norfloxacin; stability-indicating; validation;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of this study was to develop and validate a simple liquid-chromatography method, with good accuracy, reproducibility and sensitivity, for the quantification of norfloxacin in β-cyclodextrin inclusion complexes. In the method validation, the parameters evaluated were linearity, limits of detection and quantification, specificity, accuracy, precision and robustness. The stability-indication property of the method was evaluated through studies on the degradation under stress conditions. A method employing a simple mobile phase consisting of phosphate buffer (pH 3.0) and acetonitrile (86:14 v/v) was developed. Fluorescence detection was employed to minimize the influence of degradation products, due to its high sensitivity, selectivity and specificity. The method was specific, linear in the concentration range of 1 – 30 μg/mL, robust, precise and accurate. The proposed method was successfully applied in the determination of norfloxacin in inclusion complexes, thus aiding quality-control analysis in the future development of drug delivery systems.
引用
收藏
页码:1083 / 1089
页数:6
相关论文
共 111 条
  • [1] Van Bambeke F(2005)undefined Clin. Microbiol. Infect 11 256-undefined
  • [2] Michot J M(2009)undefined Infec. Dis. Clin. North Am 23 1027-undefined
  • [3] Van Eldere J(2013)undefined Eur. J. Med. Chem 66 555-undefined
  • [4] Tulkens P(2007)undefined Adv. Drug Delivery Rev 59 645-undefined
  • [5] Bolon M K(2010)undefined Int. J. Pharm 397 1-undefined
  • [6] Cheng G(2008)undefined Sci. Pharm 76 567-undefined
  • [7] Hao H(2015)undefined Expert Rev. Anti-Infect. Ther 13 131-undefined
  • [8] Dai M(2015)undefined Expert Rev. Anti-Infect. Ther 13 119-undefined
  • [9] Liu Z(2007)undefined Pharm. Res 24 585-undefined
  • [10] Yuan Z(2007)undefined J Liq. Chromatogr. Relat. Technol 30 311-undefined